Afuco™ Anti-CD33 ADCC Therapeutic Antibody (Lintuzumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized (from mouse) antibody expressed in CHO binding to human CD33. Lintuzumab is a humanized monoclonal antibody used in the treatment of cancer.
Supplier | Creative Biolabs |
---|---|
Product # | AFC-TAB-756 |
Pricing | Inquiry |
Host | Human |
Target | CD33 |
Species Reactivity | Human |
Type | ADCC enhanced antibody |
Applications | IF, IP, Neut, FuncS, ELISA, FC |
Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |